PM1024

N/A

Report date: 2023/05/19 13:51:03

Base Information

Drug NamePM1024

Drug Alias NamePM1024PM-1024

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionC-C chemokine receptor type 8 inhibitorsAnti-T cell immunoglobulin and ITIM domains

TargetsC-C chemokine receptor type 8T cell immunoglobulin and ITIM domains

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator Companies +[1] N/A

China Registration ClassN/A

Develop Information

Active Companies +[1] N/A

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A